Vol. 166 No. 1, July 5, 2004. Pages 97--109.

The Control anti-αvβ3 micrograph in the original version of [Fig. 5 A](#fig5){ref-type="fig"} was a duplicate of the Control micrograph in Fig. 6 A. The authors have indicated that this was due to a clerical error during figure preparation. A corrected version of [Fig. 5 A](#fig5){ref-type="fig"} is shown below.

![(A) ER action is blocked by function blocking antibody against α2β1 integrin, but not by antibodies against other integrins. The cells were processed as in the legend to Fig. 3, after 10-min incubation with saturating concentrations (10 μg/ml) of specific mAbs ± ER. Bar, 10 μm.](JCB_200401150R_Fig5){#fig5}

In addition, the original version of [Fig. 9 B](#fig9){ref-type="fig"} showed a composite panel for Total Erk1/Erk2 that contained three duplicated lanes. The authors have indicated that the wrong panel was inserted due to a clerical error during figure preparation. A corrected version of [Fig. 9 B](#fig9){ref-type="fig"} is shown below.

![(B) Detection of Erk1/Erk2 MAPK phosphorylated at T202 and Y204 (P-Erk1/Erk2) and total Erk1/Erk2 MAPK upon stimulation of serum-starved HUVECs with 10% FCS, ER (100 nM), endostatin (100 nM), ER and endostatin (100 nM each), FGF2 (75 ng/ml) ± heparin (100 ng/ml), VEGF (75 ng/ml), or EGF (75 ng/ml), as indicated.](JCB_200401150R_Fig9){#fig9}

The html and pdf versions of this article have been corrected. The errors remain only in the print version.
